Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

OGI strikes deal with Israeli co. to supply medical-grade cannabis

Stockhouse Editorial
0 Comments| June 10, 2020

{{labelSign}}  Favorites
{{errorMessage}}

Click to enlargeOrganigram Holdings Inc. (TSX.OGI) is the most recent Canadian cannabis company to make a deal with an Israeli firm.

The Moncton, N.B.-based pot producer said Tuesday it has entered into a seven-year agreement to supply Israeli cannabis leader Canndoc with up to 6,000 kilograms of dried flower in a multi-year strategic agreement -- Organigram’s largest international deal to date.

OGI announced in a statement that the actual value of the deal will vary depending on factors such as potency and the product mix supplied to Canndoc. Jefferies analyst Owen Bennett said in a release the deal gives Organigram valuable international exposure without incurring any significant spending.

The deal simultaneously builds a relationship with a potentially-material global cannabis partner.

New to investing in Cannabis? Check out Stockhouse tips on How to Invest in Cannabis Stocks and some of our Top Cannabis Stocks.

For more of the latest info on Cannabis, check out the Cannabis Trending News hub on Stockhouse.


{{labelSign}}  Favorites
{{errorMessage}}

Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today